Clinical Trial Update: The Effect of Ginkgolide on Clinical Improvement of Patients With Acute Ischemic Stroke [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trial update investigating the impact of ginkgolide on clinical improvement in acute ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Ginkgolide (ginkgolide)

Snippet

Sponsor: Shanghai Yueyang Integrated Medicine Hospital | Conditions: Ischemic Stroke, Acute | Phase 2, Phase 3 | Status: UNKNOWN